Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,268,585,398
-
Total 13F shares
-
990,809,599
-
Share change
-
-20,861,911
-
Total reported value
-
$57,833,324,808
-
Put/Call ratio
-
64%
-
Price per share
-
$58.40
-
Number of holders
-
1,785
-
Value change
-
-$1,248,536,302
-
Number of buys
-
898
-
Number of sells
-
830
Institutional Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q3 2020
As of 30 Sep 2020,
CVS HEALTH Corp - Common Stock (CVS) was held by
1,785 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
990,809,599 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Capital World Investors, FMR LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, WELLINGTON MANAGEMENT GROUP LLP, and NORTHERN TRUST CORP.
This page lists
1,797
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.